Fate Therapeutics Inc. buy Wedbush
Start price
27.10.25
/
50%
€1.35
Target price
27.10.26
€6.02
Performance (%)
64.31%
Price
23.07.26
€2.21
Summary
This prediction is currently active. With a performance of 64.31% the BUY prediction by Wedbush is a big success. This prediction currently runs until 27.10.26. The prediction end date can be changed by Wedbush at any time. Wedbush has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Fate Therapeutics Inc. | -7.221% | -7.221% |
| iShares Core DAX® | -0,46 % | -0,83 % |
| iShares Nasdaq 100 | -1,41 % | -3,02 % |
| iShares Nikkei 225® | -1,25 % | -7,63 % |
| iShares S&P 500 | -1,15 % | 0,59 % |
Comments by Wedbush for this prediction
In the thread Fate Therapeutics Inc. diskutieren
Fate Therapeutics (NASDAQ:FATE) was upgraded by analysts at Wedbush from a "neutral" rating to an "outperform" rating. They now have a $7.00 price target on the stock, up previously from $5.00.
Ratings data for FATE provided by MarketBeat